Bridgebio Pharma Inc. (bbio 1.75 03/01/31)
13F holders, Q2 2026 (June 30)3holders −1
1new positions
2sold out
$1.77avg. 13F price*
At the end of Q2 2026, 3 institutions reported holding Bridgebio Pharma Inc. (bbio 1.75 03/01/31) in their 13F filings, down 1 from Q1 2026. 1 opened new positions and 2 sold out. The largest holders were State of Wisconsin Investment Board ($6.7M), Oddo BHF Asset Management Sas ($383K) and Bank of New York Mellon Corp ($337K).
- Company
- Bridgebio Pharma Inc. (bbio 1.75 03/01/31)
- CUSIP
- 10806XAJ1
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $383K |
| Exits | 2 | $25.6M |
All 13F filers, Q1 2026 → Q2 2026: 1,000,227 shares bought and 4,384,000 shares sold, net −3,383,773 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| State of Wisconsin Investment Board | 0.01% | Add +33.3% | 4,000,000 | $6.7M |
| Oddo BHF Asset Management Sas | 0.02% | New | 227 | $383K |
| Bank of New York Mellon Corp | 0.00% | No change | 200,000 | $337K |
"% of holder's portfolio" is BRIDGEBIO PHARMA INC (BBIO 1.75 03/01/31)'s weight in each manager's 13F, not the share of Bridgebio Pharma Inc. (bbio 1.75 03/01/31) the manager owns.